LOSEC

This brand name is authorized in Australia, Austria, Brazil, Canada, Cyprus, Finland, Hong Kong SAR China, Ireland, Israel, Italy, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, UK.

Active ingredients

The drug LOSEC contains one active pharmaceutical ingredient (API):

1	Omeprazole UNII KG60484QX9 - OMEPRAZOLE
	Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.
	Read more about Omeprazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LOSEC Capsule, Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC01	Omeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11677N, 12270T, 8332M, 9109K, 9110L
BR	Câmara de Regulação do Mercado de Medicamentos	502302301117211, 502302302113211, 502302303111210, 502302304116216, 502315030023603, 502315030023703
CA	Health Products and Food Branch	00846503, 02190915
ES	Centro de información online de medicamentos de la AEMPS	58377
FI	Lääkealan turvallisuus- ja kehittämiskeskus	016220, 016428, 081512, 081523, 513051
GB	Medicines & Healthcare Products Regulatory Agency	139262, 139264, 139266, 139269, 14251, 14262, 14287, 143329, 143357, 143370, 143372, 143666, 14766, 14768, 14773, 175688, 196959, 199672, 199674, 199676, 199678, 199679, 199681, 381471, 387240, 399685
HK	Department of Health Drug Office	44353, 44354
IE	Health Products Regulatory Authority	32120, 32130, 32141, 32162, 32173, 65532, 66918, 66919
IL	מִשְׂרַד הַבְּרִיאוּת	1388, 3266, 5221, 5222
IT	Agenzia del Farmaco	026804082, 026804106
MT	Medicines Authority	AA1411/02301, MA639/03401
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	245M2003
NL	Z-Index G-Standaard, PRK	50407, 50415, 50423
NZ	Medicines and Medical Devices Safety Authority	13936, 4803, 4806, 4807, 8346, 8347
PL	Rejestru Produktów Leczniczych	100189833
SG	Health Sciences Authority	10699P, 10700P, 13562P
ZA	Health Products Regulatory Authority	29/11.4.3/0410, 32/11.4.3/0222, 32/11.4.3/0223, 32/11.4.3/0224, V/11.4.3/193, Z/11.4.3/98